Precision Medicine
Precision medicine aims to define and treat Parkinson’s by tailoring the right therapy to each person, depending not only on their specific signs and symptoms, but also on the specific molecular signatures of their disease.
LRRK2 and alpha synuclein interaction
Wide range of evidence supporting potential interactions
Gene linked to inherited Parkinson’s identified
TMEM230 gene association with familial cases of Parkinson’s.
Study uncovers role of PD-related gene
Scientists uncovered how LRRK2 gene regulates cellular transport.
Pesticides linked to increase in PD risk
Pesticides inhibiting ALDH enzyme and increased Parkinson’s disease risk.
Powered by
Science with
